Form CORRESP - Correspondence:
SEC Accession No. 0001387131-20-001061
Filing Date
2020-02-06
Accepted
2020-02-06 09:31:05
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 13742
  Complete submission text file 0001387131-20-001061.txt   14737
Mailing Address 509 MADISON AVE. - SUITE 1608 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 1608 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

EIN.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1220
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations